Reference
Vaidya V, et al. Comparison of charges and resource use associated with saxagliptin and sitagliptin. Health Economics Review : 7 Jul 2016. Available from: URL: http://dx.doi.org/10.1186/s13561-016-0104-8
Rights and permissions
About this article
Cite this article
Saxagliptin associated with lower healthcare costs than sitagliptin. PharmacoEcon Outcomes News 758, 29 (2016). https://doi.org/10.1007/s40274-016-3258-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3258-z